IBM's Anderon finalizes $1 billion CHIPS Act award for Albany quantum chip foundry

IBM has spent years pushing quantum computing from laboratory curiosity toward commercial reality, and its manufacturing strategy now has a major federal anchor. On September 16, 2026, Anderon LLC, an IBM company, finalized a $1 billion award under the CHIPS and Science Act with the U.S. Department of Commerce. The agreement backs Anderon's 300-millimeter pure-play quantum wafer foundry in Albany, New York, and it comes with a matching $1 billion investment from IBM itself, bringing the total commitment to roughly $2 billion. The company says the first quantum wafers are already running through the facility.

The award was first outlined in May under a letter of intent between IBM and the Commerce Department. Finalizing it turns a planned subsidy into a signed federal commitment, one that Anderon says will accelerate research and development for domestic quantum wafer manufacturing. The foundry is not a greenfield promise: Anderon says production has begun, a milestone that separates this project from the many chip announcements that remain years away from output.

Anderon operates as a pure-play foundry, meaning it intends to manufacture quantum wafers for IBM and for other developers across the quantum ecosystem rather than keeping production entirely in-house. Its specialized wafers support high-performance superconducting qubit arrays, quantum input and output signaling, and readout signal chain components. The venture has also said it plans to expand into other quantum modalities in the future.

The finalization lands within a broader federal push. The Commerce Department signed letters of intent with nine quantum companies on May 21, 2026, for a combined $2.013 billion package. IBM's proposed $1 billion was the largest single award in that group, a sign that Washington views quantum wafer fabrication as a strategic capability rather than a niche research pursuit.

Key Facts

IBM Newsroom reported on September 16, 2026 that Anderon finalized the $1 billion CHIPS and Science Act award with the U.S. Department of Commerce. The award is backed by an additional $1 billion investment from IBM. Mukesh Khare, CEO of Anderon, said in a statement: "This agreement with the Department of Commerce strengthens our ability to deliver the manufacturing scale the quantum industry needs." Khare added: "We're building a foundation that will let quantum move from research breakthroughs to real-world impact." PR Newswire reported on September 16, 2026 that the wire distribution confirmed the same terms, including the Albany, New York headquarters and the 300-millimeter wafer size.

Jay Gambetta, Director of IBM Research and an IBM Fellow, framed the deal as essential to IBM's product cadence. "IBM's quantum roadmap requires a manufacturing foundation that can scale at the pace our work demands," Gambetta said. "Anderon's focus on wafer fabrication gives us exactly that." Quartz reported on September 17, 2026 that Gambetta described Anderon as giving IBM "a reliable baseline fab" able to support its annual processor development targets.

Production is already underway. Anderon said the first quantum wafers are now running through its manufacturing facility. AIStockWire reported on September 16, 2026 that the plant is already running and that it makes wafers for superconducting qubit arrays, for quantum input and output signaling, and for readout signal chain components. A superconducting qubit is the type of quantum bit IBM builds its machines from, made of metal circuits cooled to near absolute zero. Anderon has said it plans to support other kinds of quantum computers later.

The Anderon award sits inside a wider package. Quartz reported on September 17, 2026 that the award is part of a broader $2 billion pool distributed across nine quantum computing companies under the CHIPS and Science Act. GlobalFoundries is in line for $375 million, while D-Wave Quantum, Rigetti Computing, and Infleqtion are each expected to receive $100 million. AIStockWire reported on September 16, 2026 that the total package is $2.013 billion, with letters of intent signed on May 21, 2026. PsiQuantum, Quantinuum, and Atom Computing were each down for about $100 million, and Diraq was in line for up to $38 million.

Equity terms for Anderon remain unspecified. AIStockWire reported on September 16, 2026 that most of the nine companies gave the federal government a minority ownership stake, and that D-Wave's 8-K filing shows the government received 7,095,721 shares at $14.093 each. Anderon's release does not use the words equity, stake, ownership, or shares, so its terms are unclear. The AIStockWire report also noted that the release gives no payment schedule and names no milestones. IBM shares closed Tuesday, September 15, 2026, at $248.37, and fell 3.3% on Wednesday, the day the award was announced. The stock has declined nearly 19% this year. Alphabet's Google and IonQ are not in the program.

Analysis

The Anderon award is the largest of the nine quantum awards, and its finalization says as much about federal industrial policy as it does about IBM's balance sheet. What this really means is that the U.S. government is treating quantum wafer fabrication as strategic infrastructure, not merely a research line item. The matching $1 billion from IBM also signals that the company sees manufacturing scale as a prerequisite for its quantum roadmap, not an optional add-on. The judgement here is straightforward: this deal matters more for the emerging quantum supply chain than for any single chip design.

Anderon's pure-play model is unusual in quantum computing. Many quantum firms design chips in-house or rely on conventional silicon foundries for specialized work. By offering wafers to outside customers, Anderon could become a shared manufacturing base for the sector, which would lower barriers for startups that cannot afford their own fabs. That is a meaningful shift. A pure-play foundry for quantum could do for superconducting qubits what established foundries did for classical logic chips: let designers focus on architecture while a specialist handles yield and process control.

Execution risk remains. The AIStockWire report notes that the release gives no payment schedule and names no milestones, which makes it difficult to judge how quickly the $1 billion will be deployed or what specific technical targets Anderon must hit. The bigger picture here is that CHIPS Act quantum funding is moving from announcements to obligations, and the strings attached vary by company. The lack of disclosed equity terms for Anderon is a notable gap, especially when D-Wave's filing shows the government took 7,095,721 shares at $14.093 each. Investors may want clarity on whether IBM's subsidiary gave up a similar stake.

Scale is the other consideration. A 300-millimeter wafer is the standard size used in ordinary high-volume chip plants, which suggests Anderon is building for volume rather than boutique production. That choice aligns with IBM's annual processor development targets and with the idea that quantum computers will eventually need thousands or millions of qubits. The $2.013 billion total across nine companies is modest compared with the tens of billions directed at classical semiconductor fabs, but it is focused on a technology that could reshape computing. The federal government is placing multiple bets across modalities, and Anderon's plan to expand beyond superconducting qubits fits that portfolio approach.

Why It Matters

Domestic quantum manufacturing capacity is the central issue. IBM's quantum roadmap requires a manufacturing foundation that can scale at the pace its research demands, and Anderon is designed to provide that baseline. If the foundry works as intended, it reduces IBM's dependence on external fabrication and gives the United States a homegrown source of quantum wafers. That has implications for supply chain resilience, national security, and the ability of U.S. firms to iterate quickly on qubit designs.

The fact that the first quantum wafers are already running through the Albany facility is significant. Many CHIPS Act announcements describe construction timelines and future production goals. Anderon is claiming current output, even if the volumes are small. That operational milestone could accelerate work on superconducting qubit arrays, quantum input and output signaling, and readout signal chain components, all of which are needed to move quantum systems from lab experiments to useful machines.

The broader nine-company package also matters because it spreads federal support across multiple quantum approaches. GlobalFoundries, D-Wave, Rigetti, Infleqtion, PsiQuantum, Quantinuum, Atom Computing, Diraq, and Anderon are not pursuing identical technologies. By funding a mix of foundries and system builders, the Commerce Department is hedging its bets. Anderon's plan to expand to other quantum modalities in the future could make it a common manufacturing resource for several of those efforts, which would amplify the impact of the initial $1 billion.

Next Up

Watch for Anderon to disclose customer agreements, a payment schedule, and technical milestones. The company has not yet said which outside customers will buy its wafers, nor how quickly it will expand beyond superconducting qubit arrays. IBM's annual processor development targets will be a key indicator of whether the foundry is delivering the reliable baseline fab that Gambetta described. Any clarity on government equity terms would also be notable, given the D-Wave precedent.

On the policy side, the rest of the $2.013 billion quantum package will move through finalization. GlobalFoundries, D-Wave, Rigetti, Infleqtion, PsiQuantum, Quantinuum, Atom Computing, and Diraq each have their own agreements to complete. IBM shareholders will be watching the stock, which fell 3.3% on announcement day and is down nearly 19% this year, to see whether the market treats the finalized award as a long-term positive or as another cost center. For now, the first quantum wafers are moving, and the federal government has signed on the dotted line.